All
Delving Into Clinical Research For Patients With Breast Cancer
Dr. Yuan Yuan breaks down studies for patients with breast cancer, such as the phase 3 CompassHER2 RD Trial.
Clinical Trials to Watch in Triple-Negative Breast Cancer
An expert shares information on a pair of noteworthy active trials in breast cancer that patients should be aware of.
Meet Bladder Cancer Warrior Mike and His Wife and Care Partner, Heidi
FDA Accepts sBLA For Opdivo Plus Yervoy For Some Patients with mCRC
The FDA accepted a supplemental biologics license application for Opdivo plus Yervoy as a first-line treatment for some adult and pediatric patients with colorectal cancer.
FDA Accepts NDA For Dordaviprone in H3 K27M-Mutant Diffuse Glioma
A New Drug Application has been accepted seeking accelerated approval for dordaviprone for patients with recurrent H3 K27M-mutant diffuse glioma, with a target action date of Aug. 18.
FDA Accepts Priority Review for Pre- and Postsurgical Keytruda in HNSCC
The FDA accepted for priority review a supplemental Biologics License Application for Keytruda for resectable locally advanced head and neck cancer.
Treating Lymphedema with a Simple Trinket
Buying a pretty bracelet was healing because it let me look at my lymphedema in a new light.
Understanding Biliary Tract Cancer and The Current Standard of Care
An expert explains what biliary tract cancers are and the current landscape of treatment as well as future advancements.
Some KRAS Mutations Associated With Worse Outcomes in Pancreatic Cancer
In patients with pancreatic ductal adenocarcinoma, KRAS G12D and G12V mutations hare associated with worse patient outcomes, researchers have found.
Neoadjuvant Opdivo Combo Elicits Statistically Significant OS Findings in Resectable NSCLC
Neoadjuvant Opdivo with platinum-doublet chemo had a statistically significant and clinically meaningful improvement versus chemo alone in resectable NSCLC.
What Patients With Cancer Should Know About DPD Deficiency Prior to Chemo
Dr. Gabriel A. Brooks discusses what DPD deficiency is and why it is important for patients with cancer receiving 5-FU or Xeloda to be aware of it.
FDA Grants Fast Track Designation to AUTX-703 In R/R AML
The Food and Drug Administration granted fast track designation to AUTX-703 for relapsed or refractory acute myelogenous leukemia.
Colorectal Cancer or Any Type of Cancer Can Test a Friendship
Cancer tested my friendships by showing who could stay present through tough conversations, support me emotionally and endure pain together despite the loss.
GAP Triplet May Be Less Safe Than Doublet Chemo in Biliary Tract Cancer
An expert explains that the GAP regimen did not improve overall survival in advanced biliary tract cancer versus the doublet and increased severe side effects.
Zongertinib Receives Priority Review For HER2 Mutant NSCLC
Zongertinib, an investigational treatment for HER2-mutant advanced NSCLC, has received FDA priority review, showing positive results and favorable safety.
Odronextamab is Safe and Effective in R/R DLBCL After Progression on CAR T
Odronextamab demonstrated a manageable safety profile and generated durable responses in patients with R/R DLBCL who have progressed after CAR-T therapy.
Facing Lung Cancer: My Journey from Diagnosis to Surgery
Diagnosed with early-stage lung cancer, I chose robot-assisted surgery, navigating pain, fear and the bond with fellow cancer patients through it all.
COSMIC-313 Trial Lead Breaks Down Treatment Intensification in RCC
Dr. Laurence Albiges discusses triplet therapies, highlighting which patients with RCC may garner the most benefit with this treatment intensification.
Debunking the Myth That Healthy People Don’t Get Cancer
The myth that "healthy people don’t get cancer" contributed to my shame, but I’ve learned that cancer can affect anyone, regardless of lifestyle choices.
Personalized Medicine Makes Strides Across the GU Oncology Treatment Space
Dr. Chandler Park discusses the importance of genetic testing and personalized care in patients with genitourinary cancers.
The Importance of Genetic Testing in Metastatic Colorectal Cancer
An expert explains the importance of genetic testing in metastatic colorectal cancer, as recent FDA approval highlights its role in guiding targeted treatments.
Brukinsa Shows Favorable Safety Profile Over Imbruvica in CLL
Researchers have found Brukinsa to be a potentially safer alternative for patients with chronic lymphocytic leukemia.
Cancer is Hard Enough Without Infections
As a cancer survivor, I describe battling both cancer and infections and the toll it takes on my body.
How Patients With Cancer Can Avoid Counterfeit Therapeutics Online
Dr. Megan Menon explains how patients can verify the authenticity of online prescription purchases for their cancer treatment.
Neoadjuvant Chemotherapy Plus Chemoradiation Safe, Effective in Bladder Cancer
For some patients with bladder cancer, neoadjuvant chemotherapy plus bladder-saving concurrent chemoradiation therapy was effective in the long term.
Tuspetinib Triplet Is Safe and Has Antileukemic Activity in Newly Diagnosed AML
Treatment with tuspetinib in combination with Venclexta and Vidaza in newly diagnosed acute myeloid leukemia showed safety and antileukemic activity.
Ficerafusp Alfa Trial Begins for Recurrent/Metastatic Head and Neck Cancer
Ficerafusp alfa enters phase 2/3 trial for recurrent/metastatic head and neck cancer, evaluating its combination with Keytruda for first-line treatment.
Real-World Data Confirms Safety of Bavencio and Inlyta in Advanced RCC
In a real-world analysis of patients with advanced RCC, the combination of first-line Bavencio and Inlyta was effective and safe.
How Pets Can Provide Hope for Patients With Bladder Cancer
My pet provided emotional support and helped me tolerate chemotherapy better, reducing my stress and improving my well-being throughout my cancer journey.
Personalized Cancer Vaccine Demonstrates Responses in Kidney Cancer
Dr. Catherine Wu discussed the unique aspects of clear cell renal cell carcinoma and the challenges of targeting it with a vaccine.
